Kearney-Ramos, T., Herrmann, E. S., Belluomo, I., Matias, I., Vallée, M., Monlezun, S., Piazza, P. V., & Haney, M. (2023). The Relationship Between Circulating Endogenous Cannabinoids and the Effects of Smoked Cannabis. Cannabis and Cannabinoid Research, 8(6), 1069–1078. https://doi.org/10.1089/can.2021.0185

Williams, A. R., Mauro, C. M., Feng, T., Waples, J., Martins, S. S., & Haney, M. (2023). Adult Medical Cannabinoid Use and Changes in Prescription Controlled Substance Use. Cannabis and Cannabinoid Research, 8(5), 933–941. https://doi.org/10.1089/can.2021.0212

Neuberger, A., Trofimov, Y. A., Yelshanskaya, M. V., Khau, J., Nadezhdin, K. D., Khosrof, L. S., Krylov, N. A., Efremov, R. G., & Sobolevsky, A. I. (2023). Molecular pathway and structural mechanism of human oncochannel TRPV6 inhibition by the phytocannabinoid tetrahydrocannabivarin. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-40362-2

Michel, A., Lee, R. T., Salehi, E., & Accordino, M. K. (2023). Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling. American Society of Clinical Oncology Educational Book, 43. https://doi.org/10.1200/edbk_390428

Vimal, D., D’Souza, L. C., Rai, V., Lal, S., Sharma, A., & Gupta, S. C. (2023). Efficacy of Cannabis and its Constituents in Disease Management: Insights from Clinical Studies. Current Medicinal Chemistry, 30(2), 178–202. https://doi.org/10.2174/0929867329666220525124818

Qvist, J. S., Scherma, M., Jayaram-Lindström, N., Fratta, W., Kandel, D. B., Kandel, E. R., Fadda, P., & Melas, P. A. (2022). Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence. International Journal of Molecular Sciences, 24(1), 698. https://doi.org/10.3390/ijms24010698

Andrews, C. N., Rehak, R., Woo, M., Walker, I., Ma, C., Forbes, N., Rittenbach, K., Hathaway, J., Wilsack, L., Liu, A., Nasser, Y., & Sharkey, K. A. (2022). Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence. Alimentary Pharmacology & Therapeutics, 56(11–12), 1532–1542. Portico. https://doi.org/10.1111/apt.17265

Basavarajappa, B. S., & Subbanna, S. (2022). Molecular Insights into Epigenetics and Cannabinoid Receptors. Biomolecules, 12(11), 1560. https://doi.org/10.3390/biom12111560

Patel, M., Matti, C., Grimsey, N. L., Legler, D. F., Javitch, J. A., Finlay, D. B., & Glass, M. (2022). Delineating the interactions between the cannabinoid CB2 receptor and its regulatory effectors; β‐arrestins and GPCR kinases. British Journal of Pharmacology, 179(10), 2223–2239. Portico. https://doi.org/10.1111/bph.15748

Schräder, N. H. B., Gorell, E. S., Stewart, R. E., Duipmans, J. C., Harris, N., Perez, V. A., Tang, J. Y., Wolff, A. P., & Bolling, M. C. (2021). Cannabinoid use and effects in patients with epidermolysis bullosa: an international cross-sectional survey study. Orphanet Journal of Rare Diseases, 16(1). https://doi.org/10.1186/s13023-021-02010-0